Search Results - "Stopforth RJ"

Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.

Authors: Azuly, Hovav Shafat, Tali Grupel, Daniel et al.

Source: Infectious Diseases & Therapy. Jan2025, Vol. 14 Issue 1, p167-180. 14p.

Current GMP standards for the large‐scale production of monoclonal antibodies.

Authors: Troncoso‐Bravo, Tays Pavez, Valentina Letelier, Pedro et al.

Source: Bioengineering & Translational Medicine. May2026, Vol. 11 Issue 3, p1-15. 15p.

B cell antigens: A key to optimizing CAR-T cell therapy.

Authors: Khodke, Purva Hasurkar, Dhananjay Upadhyay, Aakanksha et al.

Source: International Reviews of Immunology. 2025, Vol. 44 Issue 6, p325-352. 28p.

CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia.

Authors: Yang, Na Zhang, Caili Zhang, Yingchun et al.

Source: Journal of Translational Medicine. 3/13/2024, Vol. 22, p1-15. 15p.

The secreted protein Cowpox Virus 14 contributes to viral virulence and immune evasion by engaging Fc-gamma-receptors.

Authors: Iyer, Ravi F. Edwards, David M. Kolb, Philipp et al.

Source: PLoS Pathogens. 9/19/2022, Vol. 18 Issue 9, p1-27. 27p.

Review: progression and heterogeneity of multiple sources of mesenchymal stromal cells for the treatment of rheumatoid arthritis.

Authors: Wu, Shiyi Ding, Shuaijie Wang, Yu et al.

Source: Stem Cell Research & Therapy. 7/8/2025, Vol. 16 Issue 1, p1-13. 13p.

FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs.

Authors: Simpson, Alexander P Oldham, Robert J Cox, Kerry L et al.

Source: Clinical & Experimental Immunology. Jan2025, Vol. 219 Issue 1, p1-10. 10p.

Natural killer cells and engagers: Powerful weapons against cancer.

Authors: Bottino, Cristina Picant, Valentin Vivier, Eric et al.

Source: Immunological Reviews. Nov2024, Vol. 328 Issue 1, p412-421. 10p.

Blocking TIGIT/CD155 signalling reverses CD8⁺ T cell exhaustion and enhances the antitumor activity in cervical cancer.

Authors: Liu, Lu Wang, Aihong Liu, Xiaoli et al.

Source: Journal of Translational Medicine. 6/21/2022, Vol. 20 Issue 1, p1-13. 13p.

The diverse landscape of dermatologic toxicities of non‐immune checkpoint inhibitor monoclonal antibody‐based cancer therapy.

Authors: Seervai, Riyad N. H. Friske, Sarah K. Chu, Emily Y. et al.

Source: Journal of Cutaneous Pathology. Jan2023, Vol. 50 Issue 1, p72-95. 24p. 6 Color Photographs, 1 Diagram, 3 Charts.

Targeting the immune microenvironment in mantle cell lymphoma: implications for current and emerging therapies.

Authors: Qualls, David Kumar, Anita Epstein-Peterson, Zachary D.

Source: Leukemia & Lymphoma. Nov2022, Vol. 63 Issue 11, p2515-2527. 13p.

Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies.

Authors: Kumari, Nisha Choi, Seung Hong

Source: Journal of Experimental & Clinical Cancer Research (17569966). 2/19/2022, Vol. 41 Issue 1, p1-39. 39p.

Umbilical mesenchymal stem cell-derived extracellular vesicles as enzyme delivery vehicle to treat Morquio A fibroblasts.

Authors: Flanagan, Michael Pathak, Isha Gan, Qi et al.

Source: Stem Cell Research & Therapy. 5/6/2021, Vol. 12 Issue 1, p1-15. 15p.

Updates on CAR T‐cell therapy in B‐cell malignancies.

Authors: Jacoby, Elad Shahani, Shilpa A. Shah, Nirali N.

Source: Immunological Reviews. Jul2019, Vol. 290 Issue 1, p39-59. 21p.

Immunosuppressive therapy with rituximab in common variable immunodeficiency.

Authors: Pecoraro, Antonio Crescenzi, Ludovica Galdiero, Maria Rosaria et al.

Source: Clinical & Molecular Allergy. 5/6/2019, Vol. 17 Issue 1, pN.PAG-N.PAG. 1p. 1 Diagram.